Drugs / Japanese Encephalitis Chimeric Virus Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01001988 | Aug 2009 → Oct 2013 | Japanese encephalitis | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Japanese Encephalitis Chimeric Virus Vaccine | “Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers” NCT01001988 ↗ |
| Known as | JE-CV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01001988 ↗ |
| Modality | Vaccine | “Japanese Encephalitis Chimeric Virus Vaccine” NCT01001988 ↗ |